insights
Does intellectual property affect your startup?
According to Morgan Kirley — an intellectual property and privacy lawyer at Polsinelli and MATTER mentor — intellectual property law affects some component of every company.
We sat down with Morgan to discuss the basics that every startup needs to know.
Interested in hearing from more Polsinelli lawyers? Check back next month to hear from Lis…
Read more
insights
A discussion with Welltower CEO Tom DeRosa
The aging U.S. population is growing at its fastest rate in history. This large-scale demographic change brings with it new challenges — challenges that need innovative solutions.
In June, Tom DeRosa, CEO of Welltower and a MATTER board member, joined us at MATTER to share advice on how healthcare companies can deliver better care to the aging popula…
Read more
insights
A discussion with Dr. Shoshana Ungerleider
Last month, we hosted a screening of End Game, the Netflix documentary The New York Times calls a provocative and intimate look at how doctors, nurses and patients cope with death.
What’s it going to take for us to see talking about care at the end of life as a normal wellness practice? -@ShoshUMD #RoadtoEndWell pic.twitter.com/QpTcwZiXI0— MATT…
Read more
insights
A race is underway to develop the next major checkpoint inhibitor that harnesses the innate immune system.
At the forefront is Forty Seven, Inc., a clinical stage immuno-oncology company founded in 2015 that developed out of a lab at Stanford University. The company focuses on targeting the CD47 pathway as a way to engage macrophages — the body’s first responders — in fighting tumors.
Last mo…
Read more
insights
Most people take a medication trusting that it has been studied and approved by an official organization to be effective and safe for everyone. However, for many minority groups, that trust is not a given.
According to Kwaku Owusu, chairman of MATTER startup, Ilerasoft, and founder of Drugviu — an online platform that helps minority populations find medications that will actually work for them…
Read more